Itonis, Inc. (ITNS)
- Previous Close
0.0004 - Open
0.0004 - Bid --
- Ask --
- Day's Range
0.0004 - 0.0005 - 52 Week Range
0.0002 - 0.0013 - Volume
332,999 - Avg. Volume
7,004,387 - Market Cap (intraday)
685,534 - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
www.itonisholdings.comRecent News: ITNS
Performance Overview: ITNS
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ITNS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ITNS
Valuation Measures
Market Cap
670.30k
Enterprise Value
670.30k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-0.44
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.39M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
264
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: ITNS
Company Insights: ITNS
ITNS does not have Company Insights